Screener
BioMarin Pharmaceuticals BMRN Bridge commitment fee
Bridge commitment fee at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept bmrn:InterestExpenseBridgeCommitmentFee.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Coupon interest expense | $41,167 | $1,875 | $49,972 | $3,750 |
| Bridge commitment fee | 17,492 | — | 22,813 | — |
| Accretion of discount on convertible notes and term loans | 1,571 | 485 | 2,058 | 970 |
| Amortization of debt issuance costs | 498 | 27 | 777 | 53 |
| Total interest expense on debt | $60,728 | $2,387 | $75,620 | $4,773 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's bridge commitment fee?
- BioMarin Pharmaceuticals (BMRN) reported bridge commitment fee of $17.49M in Q2 2026.
- What does bridge commitment fee mean?
- Bridge commitment fee as reported by BioMarin Pharmaceuticals Inc.
Ask your AI about BioMarin Pharmaceuticals's bridge commitment fee.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude